News

cancer chemotherapy survivor

The new guidance, published in JACC, focuses on three classes of commonly used anticancer therapies.

cardiologists going through the certification process

After an official request from Edwards Lifesciences, CMS is rethinking its coverage policy for the use of TAVR to treat asymptomatic severe aortic stenosis. The agency is accepting public comments on this topic until Jan. 14. 

A fifth-generation TAVR valve from Edwards Lifesciences was associated with improved outcomes compared to the device's predecessors in a new real-world analysis out of Cedars Sinai.

doctor in handcuffs after being arrested

On Dec. 11, the Alaskan cardiologist was captured as part of a months-long investigation and charged with 10 counts of possessing child sexual abuse materials. The fire at his home occurred two days later.

YNHHS Main Campus

Let’s conduct a quick thought experiment. We enter a time machine and set the controls for Connecticut in 2015. As luck would have it, we land in a meeting room of the imaging department at the Yale-New Haven Health system. There we overhear a conversation. Imaging aficionados that we are, we quickly realize two groups are present—IT leaders and ranking radiologists. It’s hard to make out the exact words through the time warp. However, we clearly hear one term repeated several times: “deconstructed PACS.” 

venture capital money dollar funds VC

The most funded categories across the specialty included medical devices ($3.2B), AI software ($2.5B), and biotechnology ($2.1B). 

Lumexa Imaging

“We view this as meaningfully credit positive for its financial policy because private equity investors tend to favor high leverage to enhance their returns,” S&P notes. 

IR Centers

IR Centers, a platform company dedicated to offering minimally invasive procedures in diverse outpatient settings, is teaming with doc groups in Alabama, Texas and Virginia. 

Richard Heller, MD, MBA, FACR, senior vice president of health policy at Radiology Partners, and involved in policy advocacy with the American College of Radiology (ACR) and the Radiological Society of North America (RSNA), explains the key policy issues impacting radiology, including the CMS efficiency cuts and unfair policies by Anthem insurance.

Radiology Partners' Richard Heller, MD, MBA, outlined several mounting policy pressures providers face heading into 2026.

Arnold Seto, MD, MPA, FACC, FSCAI, cath lab director, Long Beach VA Medical Center, professor of medicine at Charles Drew University, Society for Cardiovascular Angiography and Interventions (SCAI) treasurer and chair of the SCAI Advocacy Committee, explains changes in payment policy are making ambulatory surgical centers (ASC) and office based labs (OBL) more attractive to both cardiologists and larger health systems.

ASCs have their limitations, but they are also associated with several benefits for cardiologists and patients alike.

These most recent recalls focus on a series of maintenance issues. In 2024, the FDA advised customers to transition away from the two devices and find alternative treatment options.

According to Heartflow, its AI offering saves health systems nearly $1,400 per patient thanks to reductions in unnecessary cardiovascular testing.

Around the web

The new guidance, published in JACC, focuses on three classes of commonly used anticancer therapies.

After an official request from Edwards Lifesciences, CMS is rethinking its coverage policy for the use of TAVR to treat asymptomatic severe aortic stenosis. The agency is accepting public comments on this topic until Jan. 14. 

A fifth-generation TAVR valve from Edwards Lifesciences was associated with improved outcomes compared to the device's predecessors in a new real-world analysis out of Cedars Sinai.